Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

BANK OF MONTREAL /CAN/ (BMO)

  • SEC News
  • Aug. 26, 2026, 14:14 UTC
  • 3
  • 0 comments

New Form FWP - BANK OF MONTREAL /CAN/ <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001214659-26-010877 <b>Size:</b> 141 KB

Comment Full text

MORGAN STANLEY (MS)

  • SEC News
  • Aug. 26, 2026, 14:12 UTC
  • 2
  • 0 comments

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001839882-26-041593 <b>Size:</b> 442 KB

Comment Full text

AEVEX CORP. (AVEX)

  • Business News
  • Aug. 26, 2026, 14:12 UTC
  • 0
  • 1 comments

AVEX Investors Have Opportunity to Lead AEVEX Corp. Securities Fraud Lawsuit with SBS Law

Market reaction Comment Full text

MORGAN STANLEY (MS)

  • SEC News
  • Aug. 26, 2026, 14:11 UTC
  • 2
  • 0 comments

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001839882-26-041592 <b>Size:</b> 321 KB

Comment Full text

DATAVAULT AI INC. (DVLT)

  • Business News
  • Aug. 26, 2026, 14:11 UTC
  • 0
  • 1 comments

DVLT Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Datavault AI Inc. Securities Lawsuit - Contact Levi & Korsinsky

Market reaction Comment Full text

PENTAIR PLC (PNR)

  • Business News
  • Aug. 26, 2026, 14:11 UTC
  • 0
  • 1 comments

Levi & Korsinsky Reminds Pentair plc Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of October 2, 2026 - PNR

Market reaction Comment Full text

EYEPOINT, INC. (EYPT)

  • Business News
  • Aug. 26, 2026, 14:11 UTC
  • 0
  • 1 comments

EyePoint Pharmaceuticals (EYPT) Securities Investigation Notice - Levi & Korsinsky

Market reaction Comment Full text

MORGAN STANLEY (MS)

  • SEC News
  • Aug. 26, 2026, 14:10 UTC
  • 2
  • 0 comments

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001839882-26-041591 <b>Size:</b> 430 KB

Comment Full text

UG Healthcare Corporation Limited (8K7)

  • Business News
  • Aug. 26, 2026, 14:10 UTC
  • 0
  • 1 comments

Financial Statements And Related Announcement - Full Yearly Results

Market reaction Comment Full text

AARDVARK THERAPEUTICS, INC. (AARD)

  • Business News
  • Aug. 26, 2026, 14:09 UTC
  • 0
  • 1 comments

AARD DEADLINE: Levi & Korsinsky Reminds Aardvark Therapeutics, Inc. Investors of Upcoming Securities Class Action Deadline

Market reaction Comment Full text

ITONIC HOLDINGS LTD (ITOC)

  • Business News
  • Aug. 26, 2026, 14:09 UTC
  • 0
  • 1 comments

ITOC, PTHL Shareholder Alert: iTonic Holdings Ltd (f/k/a Pheton Holdings Ltd) Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky

Market reaction Comment Full text

ALIBABA GROUP HOLDING LTD (BABA)

  • Business News
  • Aug. 26, 2026, 14:09 UTC
  • 0
  • 1 comments

BABA Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Alibaba Group Holding Securities Lawsuit - Contact Levi & Korsinsky

Market reaction Comment Full text

WIX.COM LTD. (WIX)

  • Business News
  • Aug. 26, 2026, 14:09 UTC
  • 0
  • 1 comments

WIX Deadline Alert: Levi & Korsinsky Reminds Wix.com Ltd. (WIX) Investors of Securities Class Action Deadline on September 22, 2026

Market reaction Comment Full text

PHOTRONICS INC (PLAB)

  • Business News
  • Aug. 26, 2026, 14:09 UTC
  • 0
  • 1 comments

Levi & Korsinsky Reminds Photronics, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 4, 2026 - PLAB

Market reaction Comment Full text

TABOOLA.COM LTD. (TBLA)

  • Business News
  • Aug. 26, 2026, 14:09 UTC
  • 0
  • 1 comments

TBLA Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Taboola.com Ltd. Securities Lawsuit - Contact Levi & Korsinsky

Market reaction Comment Full text
  • Previous
  • 1219
  • 1220
  • 1221
  • 1222
  • 1223
  • Next

Search

News categories

  • Technical Exchange News(14694)
  • Event(6229)
  • SEC News(393628)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(239526)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin